Additionally, studies suggest that KRT5-β-catenin interaction plays a critical role in maintaining the malignant phenotype of breast cancer cells, and targeting this pathway may serve as a novel therapeutic strategy58. This evidence concerns the gene KRT5 and breast cancer.